Literature DB >> 16418953

Local bleomycin injection in the treatment of lymphangioma.

D Baskin1, B Tander, M Bankaoğlu.   

Abstract

AIM: We report here our experience with local bleomycin injection in lymphangioma. PATIENTS AND METHODS: Nine patients with lymphangioma were treated with locally injected bleomycin and followed prospectively. We performed an ultrasound study in all cases to delineate the size, location, nature, and number of compartments of the cyst prior to the injection. Under ultrasound guidance, the content of the cystic cavity was aspirated and 1 - 3 mg/kg bleomycin were injected. The patients were revisited monthly. No attempt at re-injection was made as long as the mass continued to decrease in size.
RESULTS: Patients consisted of 4 boys and 5 girls aged between 14 days and 6 years. The localisation of the mass was cervical in 6, cervical, sublingual, and lingual in 1, axillary in 1 and axillary and thoracic in 1. In six children, the mass disappeared totally after a single injection. In one patient a second injection was needed, and surgical excision was performed in two patients with residual solid component. No complication related to bleomycin was seen.
CONCLUSION: Local application of bleomycin in children with lymphangioma is a simple, safe, and effective method. In the majority of cases, total healing may be achieved with a single injection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16418953     DOI: 10.1055/s-2005-872922

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  10 in total

1.  Treatment of lymphangioma of the face with intralesional bleomycin: case discussion and literature review.

Authors:  Sertac Yetiser; Kutlay Karaman
Journal:  J Maxillofac Oral Surg       Date:  2011-04-20

2.  Results of Intralesional Bleomycin Sclerotherapy for Treatment of Orbital Lymphangiomas at a Tertiary Eye Care Centre in Bangladesh.

Authors:  Murtuza Nuruddin; Soma Rani Roy; Hardeep Singh Mudhar
Journal:  Ocul Oncol Pathol       Date:  2019-03-12

3.  Embolization in the head and neck.

Authors:  Daniel Cooke; Basavaraj Ghodke; Sabareesh Kumar Natarajan; Danial Hallam
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

Review 4.  Vascular anomalies: what a radiologist needs to know.

Authors:  Josée Dubois; Marianne Alison
Journal:  Pediatr Radiol       Date:  2010-04-30

5.  A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations.

Authors:  Gerald M Legiehn; Manraj K S Heran
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

6.  Management of macrocystic lymphatic malformation at uncommon site with aqueous bleomycin sclerotherapy.

Authors:  Ankur Bhatnagar; Vijai Datta Upadhyaya; Rajnikant Yadav; Basant Kumar
Journal:  Natl J Maxillofac Surg       Date:  2020-12-16

7.  Efficacy and safety of ultrasound-guided bleomycin combined with dexamethasone in the treatment of pediatric lymphangiomas.

Authors:  Yu-Tong Zhang; Chao Zhang; Yu Wang; Jian Chang
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

8.  Intralesional bleomycin in lymphangioma: an effective and safe non-operative modality of treatment.

Authors:  V Kumar; P Kumar; A Pandey; D K Gupta; R C Shukla; S P Sharma; A N Gangopadhyay
Journal:  J Cutan Aesthet Surg       Date:  2012-04

9.  Abdominal cystic lymphangioma in a term newborn: A case report and update of new treatments.

Authors:  Ilaria Amodeo; Giacomo Cavallaro; Genny Raffaeli; Lorenzo Colombo; Monica Fumagalli; Riccardo Cavalli; Ernesto Leva; Fabio Mosca
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

10.  Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort.

Authors:  Frédérique C M Bouwman; Silje S Kooijman; Bas H Verhoeven; Leo J Schultze Kool; Carine J M van der Vleuten; Sanne M B I Botden; Ivo de Blaauw
Journal:  Eur J Pediatr       Date:  2020-10-13       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.